Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Oniki

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Journal of Atherosclerosis and Thrombosis|March 20, 2024
The Association of the Cholesterol Efflux Capacity with the Paraoxonase 1 Q192R Genotype and the Paraoxonase ActivityKentaro Oniki, Kayoko Ohura, Megumi Endo, et al.
Journal of Diabetes Research|July 7, 2025
Impact of Albuminuria and Renal Dysfunction on the Anemia-Improving Effect of SGLT2 Inhibitors in Patients With Type 2 Diabetes: A Real-World Observational StudyAyami Kajiwara-Morita, Kentaro Oniki, Akira Yoshida, et al.
European Journal of Clinical Pharmacology|April 26, 2014
Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery diseaseSeiji Hokimoto, Tadasuke Chitose, Michio Mizobe, et al.
Toxicology Letters|December 3, 2014
Combined effects of current-smoking and the aldehyde dehydrogenase 2*2 allele on the risk of myocardial infarction in Japanese patientsKazunori Morita, Hiroko Miyazaki, Junji Saruwatari, et al.
Cardiovascular Diabetology|May 9, 2015
Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathyHideaki Jinnouchi, Kazunori Morita, Takahiro Tanaka, et al.
Thrombosis Research|April 21, 2015
Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapySeiji Hokimoto, Tomonori Akasaka, Noriaki Tabata, et al.
Biological & Pharmaceutical Bulletin|January 7, 2020
Repeated Administration of Kupffer Cells-Targeting Nanoantioxidant Ameliorates Liver Fibrosis in an Experimental Mouse ModelHitoshi Maeda, Yuki Minayoshi, Shota Ichimizu, et al.
Pharmacogenetics and Genomics|May 18, 2016
Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysisMiki Nishimura, Mikito Ueda, Junji Saruwatari, et al.
Nutrients|February 25, 2023
Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver DiseaseYuka Nagase, Takao Satoh, Keiichi Shigetome, et al.
Biological & Pharmaceutical Bulletin|September 2, 2016
The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male VolunteersHiromi Soraoka, Kentaro Oniki, Kazuki Matsuda, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Journal of Atherosclerosis and Thrombosis|March 20, 2024
The Association of the Cholesterol Efflux Capacity with the Paraoxonase 1 Q192R Genotype and the Paraoxonase ActivityKentaro Oniki, Kayoko Ohura, Megumi Endo, et al.
Journal of Diabetes Research|July 7, 2025
Impact of Albuminuria and Renal Dysfunction on the Anemia-Improving Effect of SGLT2 Inhibitors in Patients With Type 2 Diabetes: A Real-World Observational StudyAyami Kajiwara-Morita, Kentaro Oniki, Akira Yoshida, et al.
European Journal of Clinical Pharmacology|April 26, 2014
Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery diseaseSeiji Hokimoto, Tadasuke Chitose, Michio Mizobe, et al.
Toxicology Letters|December 3, 2014
Combined effects of current-smoking and the aldehyde dehydrogenase 2*2 allele on the risk of myocardial infarction in Japanese patientsKazunori Morita, Hiroko Miyazaki, Junji Saruwatari, et al.
Cardiovascular Diabetology|May 9, 2015
Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathyHideaki Jinnouchi, Kazunori Morita, Takahiro Tanaka, et al.
Thrombosis Research|April 21, 2015
Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapySeiji Hokimoto, Tomonori Akasaka, Noriaki Tabata, et al.
Biological & Pharmaceutical Bulletin|January 7, 2020
Repeated Administration of Kupffer Cells-Targeting Nanoantioxidant Ameliorates Liver Fibrosis in an Experimental Mouse ModelHitoshi Maeda, Yuki Minayoshi, Shota Ichimizu, et al.
Pharmacogenetics and Genomics|May 18, 2016
Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysisMiki Nishimura, Mikito Ueda, Junji Saruwatari, et al.
Nutrients|February 25, 2023
Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver DiseaseYuka Nagase, Takao Satoh, Keiichi Shigetome, et al.
Biological & Pharmaceutical Bulletin|September 2, 2016
The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male VolunteersHiromi Soraoka, Kentaro Oniki, Kazuki Matsuda, et al.
Pageof 9